Newsable Asianet News on MSN
This Analyst Sees 34% Upside For SRPT Stock — Here's Why They Expect A Sustained Rally Next
Analysts at Wolfe Research upgraded Sarepta to ‘Outperform’ from ‘Peer Perform,’ with a price target of $27.
) has been revised to $25.25 / share. This is a decrease of 16.58% from the prior estimate of $30.27 dated March 25, 2026. The price target is an average of many targets provided by analysts. The ...
As of December 6, 2025, the average one-year price target for Sarepta Therapeutics is $29.96/share. The forecasts range from a low of $5.05 to a high of $194.25. The average price target represents an ...
Looking ahead to 2030, our model projects SRPT could trade at an average price of $19.44, with a potential range between $14.58 and $24.30. This represents a potential 2.6% return from today's price.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results